Session A-5 – CMC Program Design: Pioneering Biologics Development Excellence
Date:24 July
Time:13:00– 13:15 (GMT+8)
Marc Goemans
Chief Commercial Officer
Bora Biologics
Marc Goemans serves as the Chief Commercialization Officer at Bora Biologics, where he leverages his 25 years in the biopharmaceutical sector to drive the successful market introduction of new products. In this role, Marc is responsible for developing and executing commercialization strategies that ensure Bora Biologics meets the evolving needs of its clients and the broader market. Prior to joining Bora Biologics, Marc held senior leadership positions at DSM Biologics, Patheon, Consort Medical and Catalent. His expertise spans both drug substance as well as drug product, enabling him to navigate the complexities of bringing innovative solutions to market effectively. Marc is committed to fostering a collaborative environment that emphasizes cross-functional teamwork and strategic partnerships. He believes that strong relationships with clients and stakeholders are crucial for achieving commercial success. With MSc degrees in Engineering and Business Administration, Marc combines his technical knowledge with a keen understanding of market dynamics, positioning Bora Biologics for continued growth and leadership in the biopharmaceutical industry.
Speech title & Synopsis
Global CDMO view on decision making on outsourcing in the current changing economic environment